Wait for Indian generic launches gets longer
Linkedin

Wait for Indian generic launches gets longer

Mumbai : India | Oct 29, 2012 at 12:15 AM PDT
Source: India Abroad
XX XX
Views: Pending
 
I ndian generic drug makers, such as Ranbaxy [ Get Quote ], Lupin, Dr Reddy's and Aurobindo, which often opt to challenge patents in the US, might have to wait longer to launch their generic versions there. For the next few years, the US Food and Drug Administration (FDA) has extended the timeline by 10... FULL ARTICLE AT India Abroad
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 
  • New rules for Indian generic drug makers

      India Abroad
    The US Food and Drugs Administration (US FDA) recently made amendments to its law to introduce a generic drug user fee...The fee, in force since October 1, is also for applications pending without a tentative approval. Besides, drug makers will also...

More From Allvoices

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.